InvestorsHub Logo
Followers 28
Posts 1076
Boards Moderated 0
Alias Born 08/20/2006

Re: art2426 post# 196028

Thursday, 08/29/2019 10:56:29 AM

Thursday, August 29, 2019 10:56:29 AM

Post# of 331072
I agree. Intital price point is critical for long term success and large scale market exposure is not positive if it sets a price point in the consumers' mind that is not attractive long term to the company. As a small, struggling/emerging company, they have very limited leverage negotiating with a CVS (or any other major retailer). Their best leverage IS walking away and forcing CVS to come back with a better offer or risk a competitor getting an exclusive rights agreement before them and losing access to the product. Without knowing anything about the negotiations or what was ultimately offered, it is difficult at best to say whether it was good or bad. Did they have competing offers? Late stage negotiations with other retailers? Would they increase their negotiating position with these new approvals? Lot of ifs.

Mgmt group is the largest stockholder group and has the most to gain (and lose) in signing a bad or limited deal. That doesn't mean ego cant get in the way but it usually is a good motivator.

The fact CVS got that far with ghe company gives credence to the viability of the product in the market place and that alone makes the company attractive from a risk/reward standpoint.

I have been a shareholder probably going on 2 years and bought the vast majority of my shares once it dipped past 0.001. It has been in a trading range between 6-9 for awhile. To me, it looks like a transfer from investors moving on to new/existing investors accumulating.